Outset Medical, Inc. reaffirmed earnings guidance for the year 2024. The company reaffirmed its previously provided guidance for 2024 including revenue of $145 million to $153 million, growing 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.33 USD | +6.39% | +22.32% | -19.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.96% | 224M | |
+9.24% | 221B | |
+15.84% | 198B | |
+23.95% | 148B | |
+31.67% | 112B | |
+4.68% | 66.85B | |
+14.99% | 52.84B | |
+4.85% | 50.86B | |
-4.47% | 38.75B | |
-0.41% | 35.15B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024